Perceptive Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-125,399
| Closed | -$5.87M | – | 132 |
|
2017
Q2 | $5.87M | Sell |
125,399
-129,490
| -51% | -$6.06M | 0.3% | 58 |
|
2017
Q1 | $12.6M | Sell |
254,889
-12,211
| -5% | -$605K | 0.72% | 37 |
|
2016
Q4 | $16.2M | Buy |
267,100
+255,539
| +2,210% | +$15.5M | 1.15% | 22 |
|
2016
Q3 | $767K | Sell |
11,561
-55,600
| -83% | -$3.69M | 0.05% | 100 |
|
2016
Q2 | $3.75M | Sell |
67,161
-46,899
| -41% | -$2.62M | 0.26% | 64 |
|
2016
Q1 | $3.84M | Buy |
114,060
+101,260
| +791% | +$3.41M | 0.34% | 63 |
|
2015
Q4 | $578K | Sell |
12,800
-6,456
| -34% | -$292K | 0.04% | 94 |
|
2015
Q3 | $761K | Sell |
19,256
-307,901
| -94% | -$12.2M | 0.06% | 90 |
|
2015
Q2 | $20.3M | Buy |
327,157
+19,373
| +6% | +$1.2M | 1.22% | 14 |
|
2015
Q1 | $19.3M | Sell |
307,784
-4,716
| -2% | -$295K | 1.5% | 19 |
|
2014
Q4 | $17.6M | Buy |
+312,500
| New | +$17.6M | 1.48% | 19 |
|
2014
Q2 | – | Sell |
-45,000
| Closed | -$1.41M | – | 114 |
|
2014
Q1 | $1.41M | Buy |
+45,000
| New | +$1.41M | 0.15% | 76 |
|